Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
64.25
-0.88 (-1.34%)
At close: Mar 9, 2026, 4:00 PM EDT
64.04
-0.20 (-0.32%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Utah Medical Products Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 205 | 179 | 208 | 306 | 365 | 365 | Upgrade
|
| Market Cap Growth | -0.68% | -14.01% | -31.80% | -16.18% | -0.11% | 18.97% | Upgrade
|
| Enterprise Value | 118 | 95 | 120 | 218 | 296 | 301 | Upgrade
|
| Last Close Price | 65.12 | 55.96 | 60.18 | 80.98 | 95.39 | 93.64 | Upgrade
|
| PE Ratio | 18.70 | 15.89 | 15.03 | 18.38 | 22.14 | 24.69 | Upgrade
|
| Forward PE | - | 17.80 | 17.80 | 17.80 | 17.80 | 17.80 | Upgrade
|
| PS Ratio | 5.28 | 4.65 | 5.10 | 6.09 | 6.98 | 7.44 | Upgrade
|
| PB Ratio | 1.74 | 1.50 | 1.78 | 2.38 | 3.19 | 3.41 | Upgrade
|
| P/TBV Ratio | 1.95 | 1.72 | 2.07 | 2.79 | 4.03 | 4.85 | Upgrade
|
| P/FCF Ratio | - | - | 14.28 | 14.12 | 17.93 | 17.68 | Upgrade
|
| P/OCF Ratio | - | - | 14.06 | 13.72 | 17.25 | 17.22 | Upgrade
|
| PEG Ratio | - | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | Upgrade
|
| EV/Sales Ratio | 3.06 | 2.47 | 2.94 | 4.34 | 5.65 | 6.14 | Upgrade
|
| EV/EBITDA Ratio | 8.20 | 6.64 | 6.49 | 8.80 | 11.02 | 11.51 | Upgrade
|
| EV/EBIT Ratio | 10.32 | 8.35 | 7.65 | 11.81 | 14.93 | 15.95 | Upgrade
|
| EV/FCF Ratio | - | - | 8.24 | 10.06 | 14.53 | 14.58 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.02 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.72 | -0.72 | -0.70 | -0.72 | -0.65 | -0.56 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.96 | -5.96 | -4.46 | -3.74 | -2.79 | -2.32 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -5.66 | -4.28 | -3.67 | -2.93 | Upgrade
|
| Asset Turnover | 0.31 | 0.31 | 0.32 | 0.39 | 0.44 | 0.43 | Upgrade
|
| Inventory Turnover | 1.97 | 1.97 | 1.82 | 2.19 | 2.61 | 2.83 | Upgrade
|
| Quick Ratio | 34.36 | 34.36 | 23.18 | 20.44 | 13.52 | 17.65 | Upgrade
|
| Current Ratio | 37.62 | 37.62 | 25.64 | 22.56 | 15.09 | 19.54 | Upgrade
|
| Return on Equity (ROE) | 9.54% | 9.54% | 11.29% | 13.72% | 14.88% | 14.09% | Upgrade
|
| Return on Assets (ROA) | 5.82% | 5.82% | 7.62% | 8.89% | 10.33% | 10.38% | Upgrade
|
| Return on Invested Capital (ROIC) | 26.84% | 26.62% | 36.84% | 40.56% | 36.65% | 29.85% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.50% | 9.50% | 13.20% | 14.10% | 16.80% | 16.90% | Upgrade
|
| Earnings Yield | 5.55% | 6.30% | 6.65% | 5.44% | 4.52% | 4.05% | Upgrade
|
| FCF Yield | - | - | 7.00% | 7.08% | 5.58% | 5.66% | Upgrade
|
| Dividend Yield | 1.93% | 2.19% | 2.00% | 1.46% | 1.22% | 0.91% | Upgrade
|
| Payout Ratio | 35.31% | - | 30.70% | 25.74% | 19.20% | 77.53% | Upgrade
|
| Buyback Yield / Dilution | 7.51% | 7.51% | 3.68% | 0.16% | 0.46% | 0.33% | Upgrade
|
| Total Shareholder Return | 9.47% | 9.70% | 5.68% | 1.63% | 1.69% | 1.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.